Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.23.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.23.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.23.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.23.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.21.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.21.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.21.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.21.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
XBB.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.42ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.42ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.42NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.4.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GR.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GR.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used